These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29739108)

  • 1. Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer.
    Stefanescu H; Muntean D; Pilut C; Diaconu M; Popescu R; Hutanu D; Moise M; Diana L; Nitu R; Cherecheanu AP; Negoita S; Iovan CV; Ungureanu E; Calu V; Ciuca I
    Clin Lab; 2018 Mar; 64(3):257-262. PubMed ID: 29739108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
    Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
    Luo X; Stock C; Burwinkel B; Brenner H
    PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNAs Expression as Novel Genetic Biomarker for Early Prediction and Continuous Monitoring in Pulmonary Cancer.
    Nitu R; Rogobete AF; Gundogdu F; Tanasescu S; Boruga O; Sas A; Popovici SE; Hutanu D; Pilut C; Sarau CA; Candea AC; Stan AT; Moise LM
    Biochem Genet; 2017 Aug; 55(4):281-290. PubMed ID: 28070693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA dysregulation in colorectal cancer: a clinical perspective.
    Dong Y; Wu WK; Wu CW; Sung JJ; Yu J; Ng SS
    Br J Cancer; 2011 Mar; 104(6):893-8. PubMed ID: 21364594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
    Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
    Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
    Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of microRNA-451a as a Novel Circulating Biomarker for Colorectal Cancer Diagnosis.
    Zhang Z; Zhang D; Cui Y; Qiu Y; Miao C; Lu X
    Biomed Res Int; 2020; 2020():5236236. PubMed ID: 32908896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients.
    Fesler A; Jiang J; Zhai H; Ju J
    Mol Diagn Ther; 2014 Jun; 18(3):303-8. PubMed ID: 24566942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.